CDK7 and cancer: Studies have demonstrated that the dysregulation of CDK7 was involved in various types of cancers and considered to be positively correlated with the aggressive clinicopathological features of these cancers, including esophageal cancer, hepatocellular carcinoma, gastric cancer, and colorectal cancer (13, 60–62).